{
    "Trade/Device Name(s)": [
        "Advisor Pro Platform",
        "Advisor Pro Algorithm",
        "Advisor Pro Bolus Calculator",
        "DreaMed Diary App"
    ],
    "Submitter Information": "DreaMed Diabetes Ltd.",
    "510(k) Number": "K210561",
    "Predicate Device Reference 510(k) Number(s)": [
        "K201476",
        "K150910"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "QCC",
        "NDC"
    ],
    "Summary Letter Date": "September 28, 2021",
    "Summary Letter Received Date": "February 25, 2021",
    "Submission Date": "February 22, 2021",
    "Regulation Number(s)": [
        "21 CFR 862.1358"
    ],
    "Regulation Name(s)": [
        "Insulin Therapy Adjustment Device"
    ],
    "Analyte Class(es)": [
        "endocrine",
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Continuous Glucose Monitor (CGM)",
        "Self-Monitoring Blood Glucose (SMBG) meter"
    ],
    "Method(s)/Technology(ies)": [
        "Decision-support software",
        "Algorithmic analysis"
    ],
    "Methodologies": [
        "Insulin therapy adjustment",
        "Treatment recommendation software"
    ],
    "Submission Type(s)": [
        "Software",
        "Algorithm",
        "Calculator",
        "Platform",
        "App"
    ],
    "Document Summary": "FDA 510(k) summary for DreaMed Advisor Pro Platform software providing algorithmic insulin therapy recommendations and bolus calculator for diabetes management",
    "Indications for Use Summary": "Intended for management of diabetes by enabling data tracking, sharing, communication, and providing healthcare professionals with insulin therapy adjustment recommendations and bolus dose calculations for patients with type 1 diabetes (age >6) and type 2 diabetes (age >10) using subcutaneous insulin therapy.",
    "fda_folder": "Clinical Chemistry"
}